Diagnostic Labs Test Menu
1011
Fibrinogen Activity
This assay measures fibrinogen activity. Versiti is temporarily unable to report a Fibrinogen Activity:Fibrinogen Antigen ratio or provide an interpretation when both the Fibrinogen Activity Assay (Order Code: 1011) and Fibrinogen Antigen Assay (Order Code: 1508) are ordered.USA test status: This is an In Vitro Diagnostic test (IVD).
1012
Fibrinogen Antigen - TEMPORARILY UNAVAILABLE
Effective October 23, 2023, and until we can validate a new in-house assay, any samples received for the Fibrinogen Antigen Assay (Order Code 1012) will be passed through, processed, and resulted by our send-out partner, ARUP. For information about the pass-through Fibrinogen Antigen Assay, refer to order code 1508. USA test status: This is a laboratory developed test (LDT).
1021
Factor II Activity
This assay measures activity of factor II. USA test status: This is a laboratory developed test (LDT).
1024
Prothrombin Gene Mutation (G20210A)
This molecular test evaluates individuals for the prothrombin G20210A variant (F2 c.*97G7>A) associated with increased risk of venous thromboembolism. USA test status: This is a laboratory developed test (LDT).
1025
Factor II Inhibitor Profile
This order includes both Factor II Activity and Factor II Inhibitor. USA test status: This is a laboratory developed test (LDT).
1031
Protein C Activity
This test provides the activity level of the blood coagulation factor, Protein C. This protein is one of the regulatory proteins in the blood clotting cascade. USA test status: This is an In Vitro Diagnostic test (IVD).
1033
Protein C Antigen
This test provides the antigen level of the blood coagulation factor, Protein C. This protein is one of the regulatory proteins in the blood clotting cascade. USA test status: This is a laboratory developed test (LDT).
1035
Factor V Leiden (G1691A)
This molecular test evaluates individuals for the germline Factor V Leiden variant (F5 c. 1601G7A, p.Arg534Gln; Legacy nomenclature G1691A), which is associated with an increased risk of venous thromboembolism. USA test status: This is a laboratory developed test (LDT).
1041
Protein S Activity
This test provides the activity level of the blood coagulation factor, Protein S. This protein is one of the regulatory proteins in the blood clotting cascade. USA test status: This is an In Vitro Diagnostic test (IVD).
1042
Protein S Antigen, Total and Free
This test provides the antigen level of the blood coagulation factor, Protein S. This protein is one of the regulatory proteins in the blood clotting cascade. USA test status: This is an In Vitro Diagnostic test (IVD).
1043
Protein S Antigen, Free
This test provides the antigen level of the blood coagulation factor, Protein S. This protein is one of the regulatory proteins in the blood clotting cascade. USA test status: This is an In Vitro Diagnostic test (IVD).
1050
VWF Inhibitor Panel
Order set includes VWF Inhibitor Screen mixing study and VWF:GPIbM Activity. If the VWF GPIbM result is >= 50 IU/dL, the inhibitor screen is invalid and will be cancelled and credited. USA test status: This is a laboratory developed test (LDT).
1051
Factor V Activity
This assay measures activity of factor V. USA test status: This is a laboratory developed test (LDT).
1055
Factor V Inhibitor Profile
This order set includes both Factor V Activity and Factor V Inhibitor. USA test status: This is a laboratory developed test (LDT).
1056
Anti-VWF Antibody IgG and IgM
This assay quantifies anti-VWF antibodies IgG and IgM using an ELISA plate method to support diagnosis of acquired von Willebrand disease. USA test status: This is a laboratory developed test (LDT).
1062
VWF Antigen
This assay measures a patient's total vWF protein level, independent of the multimer composition of the plasma. USA test status: This is a laboratory developed test (LDT).
1063
VWF Quantitative Multimer
Quantitative multimer analysis provides an objective measure of VWF structure to characterize subtle changes observed in the subtypes of VWD and may help to determine the nature of any additional clinical laboratory testing to reach a clear-cut diagnosis. USA test status: This is a laboratory developed test (LDT).
1067
VWD Type 2B Evaluation
This order set includes VWD Type 2B Binding and VWD Type 2B Quantitative Multimer. USA test status: This is a laboratory developed test (LDT).